Cargando…
Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor
Primary hepatic neuroendocrine tumor (PHNET) is rare liver cancer and related prognostic factors are unclear. The aim of this study was to analyze the prognostic risk factors of patients with PHNETs and establish an assessment model for prognosis. The clinical information of 539 patients with PHNETs...
Autores principales: | Lin, Jianyang, Li, Xiang, Ding, Xin, Chen, Zhihong, Wu, Yinyan, Zhao, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679223/ https://www.ncbi.nlm.nih.gov/pubmed/36425110 http://dx.doi.org/10.3389/fmed.2022.960235 |
Ejemplares similares
-
Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database
por: Zhang, Ziteng, et al.
Publicado: (2021) -
Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors()()
por: Miao, Dong-liu, et al.
Publicado: (2018) -
Long-term survival in a dog with primary hepatic neuroendocrine tumor treated
with toceranib phosphate
por: ICHIMATA, Masanao, et al.
Publicado: (2021) -
Predicting the Survival Probability of Neuroendocrine Tumor Populations: Developing and Evaluating a New Predictive Nomogram
por: Chen, Jian-Xian, et al.
Publicado: (2021) -
A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms
por: Zhang, Sheng, et al.
Publicado: (2019)